Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.13 M1.96 M1.99 M2.59 M1.69 M 8.22 M Research & development 955 K568 K462 K420 K697 K 2.15 M Operating income -3.09 M-2.53 M-2.45 M-3.01 M-15.92 M -23.9 M Non-Operating Income, Total -272 K1.59 M134 K131 K127 K 1.98 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -272 K1.59 M134 K131 K127 K 1.98 M Unusual income/expense ————— — Pretax income -3.36 M-938 K-2.31 M-2.88 M-15.79 M -21.92 M Equity in earnings ————— — Taxes 000-1.7 M0 -1.7 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -3.36 M-938 K-2.31 M-1.18 M-15.79 M -20.22 M Discontinued operations ————— — Net income -3.36 M-938 K-2.31 M-1.18 M-15.79 M -20.22 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -3.36 M-938 K-2.31 M-1.18 M15.79 M 11.36 M Basic earnings per share (Basic EPS) -0.21-0.06-0.14-0.06-0.91 -1.17 Diluted earnings per share (Diluted EPS) -0.21-0.06-0.14-0.06-0.91 -1.17 Average basic shares outstanding 15.92 M15.92 M16.93 M16.51 M17.27 M — Diluted shares outstanding 15.92 M15.92 M16.93 M16.51 M17.27 M — EBITDA -2.12 M-1.97 M-1.98 M-2.59 M-15.2 M -21.75 M EBIT -2.13 M-1.97 M-1.98 M-2.6 M-15.21 M -21.75 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2 00003 0002 0002 000 7 000